Hamburg: FDA could have acted more aggressively with compounders

Testifying at a House hearing Tuesday, FDA Commissioner Dr. Margaret Hamburg admitted that her agency could have acted more aggressively against the New England Compounding Center, a pharmacy tied to a deadly meningitis outbreak last fall. "I think we allowed ourselves to be far too cautious because of fears of litigation that might further undermine our authority," Hamburg said. She also repeated concerns about the FDA's lack of influence over these pharmacies, saying it needs greater authority to make compounders follow tighter standards of safety.

View Full Article in:

New York Times (tiered subscription model), The · Hill, The · Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Claims Director
PacificSource
Springfield, OR
Director of ASO Department
Bluegrass Family Health
Lexington-or could be in Nashville, TN, KY
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Mgr NGS Provider Enrollment (I)
National Government Services - WellPoint
Harrisburg, PA
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA